What Viruses Might Do for a Living

Imagine, if you will, a committee of our brightest biochemists meeting in the late 1960s trying to make guesses about what might be happening next in the field of molecular biology. If they'd stayed up all night for weeks at a time, it is highly improbable that anyone could have guessed that recombinant DNA would happen next, or that this research technology would soon become the most important advance in biological science of the 20th century, much less that we would be purifying and scrutinizi

Written byLewis Thomas
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

It's already commonplace to hear that the next great surge in biomedical science, already well underway, will be in the field of neurobiology, and I agree with this one. I have no trouble at all in accepting the prediction that the events ahead in our comprehension of the human brain, including those strangest of all natural phenomena—human consciousness, awareness and language— are going to sweep us off our feet someday.

The trouble with saying things like this is that when the astonishments do begin coming in, some will be heard to say "Ah, yes, that's exactly the kind of thing I knew was going to happen. No surprise at all; my group told you so."

But maybe we should each be allowed just one prediction, and not one so general in nature. Something more specific and explicit than, say, the prediction that human consciousness will someday come into view.

Well, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies